However, previous studies have found that DPP-4 can be regulated by inflammatory factors such as signal transducer and activator of transcription 1 (STAT1), hepatocyte nuclear factor-1 (HNF-1), interleukin-12 (IL-12), and tumor necrosis factor- (TNF-) [33,34,35]
However, some people experience headaches, particularly when starting Semaglutide treatments
(NIDDK) I also see a second misconception: that success on these medications is purely about eating less. In reality, the reason many patients do better with GLP-1-based treatment is that these medications can change the biology driving overeating, poor fullness signaling, and dysregulated blood sugar
In the case of semaglutide, the J Code plays a vital role
But if you are looking for every possible edge in managing digestive side effects, injection site rotation is one more variable to experiment with